Qualifying Conditions Of Medical Cannabis License Holders In The United States

Abstract The evidence for cannabis’s treatment efficacy across different conditions varies widely, and comprehensive data on the conditions for which people use cannabis are lacking.

August 1, 2024

Pure delta-9-tetrahydrocannabinol and its combination with cannabidiol in treatment-resistant Tourette syndrome: A case report

Please use this link to access this publication. Abstract Objectives Anecdotal reports and preliminary studies suggest a therapeutic potential of cannabis in Tourette syndrome. We

Pulmonary effects of inhaled cannabis smoke

Please use this link to access this publication. ABSTRACT Background: The smoke generated from cannabis delivers biologically active cannabinoids and a number of combustion-derived toxins, both

Public health monitoring of cannabis use in Europe: prevalence of use, cannabis potency, and treatment rates

ABSTRACT Background Cannabis is one of the most widely used substances worldwide. Heavy use is associated with an increased risk of cannabis use disorders, psychotic

October 7, 2024

Public health impacts to date of the legalisation of medical and recreational cannabis use in the USA

Please use this link to access this publication. Abstract The legality of cannabis use has been changing in a number of jurisdictions around the world. In the

May 16, 2025

PTSD Symptom Reports of Patients Evaluated for the New Mexico Medical Cannabis Program

Background: New Mexico was the first state to list post-traumatic stress disorder (PTSD) as a condition for the use of medical cannabis. There are no

September 19, 2019

PTSD symptom reports of patients evaluated for the New Mexico Medical Cannabis Program

Abstract   Background: New Mexico was the first state to list post-traumatic stress disorder (PTSD) as a condition for the use of medical cannabis. There are

August 16, 2023

Psychosocial and pharmacological treatments for cannabis use disorder and mental health comorbidities: a narrative review

Please use this link to access this publication. Abstract Cannabis is the most widely used illicit drug worldwide, and it is estimated that up to

June 20, 2025

Psychosis associated with cannabis withdrawal: systematic review and case series

Abstract BackgroundAbrupt cessation of heavy cannabis use can cause a withdrawal syndrome characterised by irritability, anxiety, insomnia, reduced appetite and restlessness. Recent reports have also

November 8, 2025

Psychopathological and Cognitive Effects of Therapeutic Cannabinoids in Multiple Sclerosis: A Double-Blind, Placebo Controlled, Crossover Study

Abstract Objectives: To study possible psychopathological symptoms and cognitive deficits, abuse induction, as well as general tolerability and effects on quality of life, fatigue and motor

September 19, 2019